ALT is more liver-associated, while AST is also found in muscle and other tissues. Pattern, magnitude, trajectory, bilirubin/alk phos, medications, alcohol, metabolic risk, viral risk, muscle injury, and synthetic-function markers determine what an elevation means.
CLINICAL PRINTABLE
Coming Soon.
Coming Soon. A one-page AST / ALT Elevation clinical reference is on the way.
1 · Interpretation Framework
- AST (aspartate aminotransferase) and ALT (alanine aminotransferase) are released from hepatocytes when they are injured or die — they are markers of hepatocellular injury, not liver function.
- ALT is more liver-specific. AST is also found in cardiac muscle, skeletal muscle, kidneys, brain, and red blood cells — an isolated AST elevation without ALT elevation should prompt consideration of extrahepatic sources.
- Magnitude: mild (< 3× ULN), moderate (3–10× ULN), marked (> 10× ULN). Marked elevation narrows the differential significantly — consider ischemic hepatitis, acute viral hepatitis, drug/toxin injury, or autoimmune hepatitis.
- Pattern: hepatocellular (AST/ALT predominant) vs. cholestatic (alk phos/GGT predominant) vs. mixed. The pattern guides the differential and the next workup step.
- AST:ALT ratio > 2:1 in the context of alcohol use suggests alcoholic liver disease — but this ratio is not specific and should not be used in isolation.
- Synthetic function (INR, albumin, bilirubin) determines severity — elevated aminotransferases with normal synthetic function suggest injury without failure; impaired synthetic function indicates more severe disease.
2 · Nuance
Medications and supplements
Medications and supplements are among the most common and reversible causes of aminotransferase elevation. Always review the full medication list — including OTC drugs, herbals, and supplements. DILI (drug-induced liver injury) can mimic any pattern of liver disease.
Muscle injury
Rhabdomyolysis, intense exercise, myositis, and cardiac injury can elevate AST significantly without liver disease. If AST is elevated but ALT is normal or minimally elevated, check CK to assess for muscle source.
Ischemic hepatitis
Ischemic hepatitis (shock liver) produces dramatic aminotransferase elevation — often > 1000–10,000 U/L — in the setting of hypoperfusion. It typically follows a period of hemodynamic instability and resolves rapidly with restoration of perfusion.
Steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) may produce mild to moderate aminotransferase elevation — or normal enzymes. Normal AST/ALT does not exclude significant hepatic steatosis or fibrosis.
Falling aminotransferases in acute liver failure
In severe acute hepatic failure, falling aminotransferases may reflect loss of viable hepatocytes rather than recovery. Assess synthetic function (INR, bilirubin) — not just the enzyme trend — to determine trajectory.
3 · What Should Raise Concern
- Marked aminotransferase elevation (> 10× ULN) — consider ischemic hepatitis, acute viral hepatitis, drug/toxin injury, or autoimmune hepatitis. Urgent evaluation is warranted.
- Elevated aminotransferases with rising INR, rising bilirubin, or falling albumin — suggests hepatic synthetic failure. Hepatology consultation and consideration of acute liver failure workup.
- Falling aminotransferases in a patient who is clinically worsening — may reflect loss of viable hepatocytes, not recovery. Do not be falsely reassured.
- New aminotransferase elevation in a patient on a hepatotoxic medication — assess for DILI and consider stopping the offending agent.
4 · What Do I Do Next?
- Classify the pattern: hepatocellular, cholestatic, or mixed. Then assess magnitude and synthetic function.
- Review medications and supplements — this is the most common reversible cause and is often missed.
- For hepatocellular pattern: check viral hepatitis serologies (HBsAg, anti-HCV, anti-HAV IgM), consider autoimmune hepatitis panel (ANA, ASMA, anti-LKM), and assess for alcohol use and metabolic risk factors.
- If AST is elevated without ALT elevation, check CK to assess for muscle source before attributing to liver.
- Assess synthetic function (INR, albumin, total bilirubin) to determine severity and guide urgency of hepatology referral.
Apply It · Patient Cases
CASE 1
A 48-year-old presents with AST 1,800 U/L and ALT 2,100 U/L after an episode of hypotension from GI bleeding. Ischemic hepatitis is suspected. INR is 1.4. With hemodynamic stabilization, aminotransferases fall rapidly over 48–72 hours — confirming the ischemic etiology.
CASE 2
A 35-year-old with no known liver disease has AST 85 U/L and ALT 22 U/L on routine labs. The disproportionate AST elevation prompts a CK — it is 4,200 U/L, consistent with subclinical rhabdomyolysis from recent intense exercise. No liver workup is needed.
NOW CHANGE ONE DETAIL
Same patient as Case 2, but CK is normal. The isolated AST elevation without a muscle source now warrants liver evaluation — hepatitis serologies, medication review, and metabolic risk assessment are initiated.
Bottom Line
AST/ALT are injury markers. Pattern + context + bilirubin/alk phos + synthetic function tell you what the injury means — not the number alone.
EVIDENCE & REFERENCES
- Kwo PY, et al. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18–35. doi:10.1038/ajg.2016.517
- Chalasani N, et al. The diagnosis and management of nonalcoholic fatty liver disease. Hepatology. 2018;67(1):328–357. doi:10.1002/hep.29367
- Naveau S, et al. Excess weight risk factor for alcoholic liver disease. Hepatology. 1997;25(1):108–111. doi:10.1002/hep.510250120